Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
---|---|---|---|---|
1.1 | The pharmacy has undertaken some risk assessments of its services including a risk assessment for the supply of weight loss medicines and the sale of Pharmacy Only (P) medicines online. But it does not have an overarching risk assessment that shows how it has considered and mitigated all of the risks of the model it is using including the overall risks of the service, ensuring prescribers have the right competencies for the treatments provided, ensuring appropriate records are kept and staff communication. And the pharmacy is not following its own procedures for the supply of P medicines which are liable to misuse, overuse or abuse. |
We have updated the risk assessment to ensure that all prescribers involved in weight management services are competent and appropriately trained in this area. We have acknowledged in the risk assessment that a prescriber lacking competence in weight loss management can result in an incorrect or inappropriate prescription, which poses significant clinical risk. This has been formally included in the prescriber risk category and preventative measures sections. We have ensured that prescribers leave clear notes on each order, explaining the rationale behind their clinical decisions and the process followed in reaching those decisions. These notes are accessible to pharmacy owners, providing full visibility and allowing them to review and understand the prescriber’s clinical reasoning. We have implemented a process where a note is made for each sale of P medicines that are liable to abuse. Customers are proactively contacted to assess the clinical need for the medication, particularly if requested frequently. Where necessary, the Summary Care Record (SCR) is accessed to confirm ongoing conditions, with prior consent obtained from the customer; if consent is not given, the sale may be declined. Additionally, verification occurs through an external agency, and if verification fails, the customer is contacted directly. Purchase patterns are assessed, and repeat orders are flagged. |
23/05/2025 | 14/05/2025 |
1.6 | The pharmacy cannot show that it keeps all the records it needs to for the safe provision of its services. It was unable to show that the prescriber made appropriate clinical records for consultations and prescribing decisions for the weight management. And the pharmacy does not routinely record the reasons it has supplied P medicines, particularly for medicines liable to abuse, misuse or overuse. |
We have ensured that all private prescriptions are recorded in the Patient Medication Record (PMR) system, with records securely stored and available for access when needed. Additionally, records are maintained on the online portal for added accessibility. Prescriber records and notes are systematically stored and are available for access by the necessary parties. For all P medicine sales, the reasons for supply are clearly documented. |
23/05/2025 | 06/05/2025 |
3.1 | There is excessive clutter and boxes on the stairs and the front entrance. This presents a significant health and safety risk. |
All unnecessary clutter has been cleared, and empty boxes have been properly discarded. The pharmacy is cleaned regularly, and walkway areas are kept clear at all times to eliminate potential hazards and maintain a safe working environment. |
23/05/2025 | 06/05/2025 |
4.2 | The pharmacy was unable to provide satisfactory records of the prescriber’s clinical notes and prescribing decisions. There were no records to show the prescriber had considered the additional risks of prescribing where there was no consent to contact the person's regular prescriber. And where consent was given the pharmacy could not show that they were contacting the person’s regular prescriber. The pharmacists could not show that they were supplying P medicines that had a risk of abuse, misuse, or overuse safely. They were not completing ID checks or recording their decision to sell medicines to show that they had considered all the risks. |
We have ensured that no sale is made unless the customer provides permission to inform their GP. All letters sent to the patient’s regular GP are recorded and remain easily accessible to both the prescriber and pharmacy owners. Consent to contact GP is mandatory and customer cannot complete consultation without providing GP details and consent. Additionally, ID checks for P medicines are carried out using LexisNexis, and if verification is unsuccessful customer is contacted. |
23/05/2025 | 06/05/2025 |